Invitation to Conference Call Regarding Promore Pharma's Interim Report for the Third Quarter 2022

STOCKHOLM, SE / ACCESSWIRE / November 24, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0) STOCKHOLM, 24 November 2022 - Promore Pharma AB (publ) publishes its interim report for the third quarter 2022 on 29

Related Keywords

Sweden ,Stockholm ,Swedish ,Promore Pharma ,Promore Pharmaview ,Erik Magnusson ,Jonas Ekblom , ,Hamnen Corporate Finance Youtube ,Pharmas Certified Adviser ,Erik Penser ,Nasdaq First North Growth ,Conference Call ,Interim Report ,Third Quarter ,Invitation ,Conference ,Wall ,Egarding ,Dromore ,Dharma ,Interim ,Report ,Third ,Quarter ,022 ,